Zobrazeno 1 - 2
of 2
pro vyhledávání: '"On Behalf Of The AdAM Study Group"'
Autor:
Robin Brünn, Dorothea Lemke, Jale Basten, Petra Kellermann-Mühlhoff, Juliane Köberlein-Neu, Christiane Muth, Marjan van den Akker, on behalf of the AdAM Study Group
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 759 (2022)
Polypharmacy is associated with a risk of negative health outcomes. Potentially inappropriate medications, interactions resulting from contradicting medical guidelines, and inappropriate monitoring, all increase the risk. This process evaluation (PE)
Externí odkaz:
https://doaj.org/article/4f32c076a73c426fb6f8f86c7d97ade3
Autor:
Brünn R; Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany., Lemke D; Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany., Basten J; Department of Medical Informatics, Biometry and Epidemiology, Ruhr University, 44789 Bochum, Germany., Kellermann-Mühlhoff P; BARMER, Statutory Health Insurance, 42285 Wuppertal, Germany., Köberlein-Neu J; Center for Health Economics and Health Services Research, Schumpeter School of Business and Economics, University of Wuppertal, 42119 Wuppertal, Germany., Muth C; Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany.; Department of General Practice and Family Medicine, Medical Faculty East-Westphalia, University of Bielefeld, 33615 Bielefeld, Germany., van den Akker M; Institute of General Practice, Goethe University, 60590 Frankfurt am Main, Germany.; Department of Family Medicine, Care and Public Health Research Institute, Maastricht University, 6200 Maastricht, The Netherlands.; Department of Public Health and Primary Care, Academic Centre of General Practice, KU Leuven, 3000 Leuven, Belgium., On Behalf Of The AdAM Study Group
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Jun 17; Vol. 15 (6). Date of Electronic Publication: 2022 Jun 17.